Aether Industries has reported a robust fiscal year 2026, with consolidated revenue of ₹11,601 million, marking a 38% year-on-year growth. The company achieved an EBITDA of ₹3,547 million, representing a 31% margin. Despite a quarterly dip in Q4 due to one-off inventory write-offs and logistics challenges, the firm remains focused on its long-term strategy, prioritizing expansion in CRAMS and CEM business models and commissioning of key new sites.
Financial Highlights of FY26
For the financial year ended March 31, 2026, Aether Industries delivered strong growth, with annual consolidated revenue rising to ₹11,601 million compared to ₹8,406 million in FY25. Profit After Tax (PAT) also saw a significant increase of 39% year-on-year, reaching ₹2,195 million with a PAT margin of 19%. The annual EBITDA margin improved to 31%, up from 28% in the previous year.
Quarterly Performance and Strategic Outlook
During Q4 of FY26, the company reported revenue of ₹3,051 million. Performance was temporarily impacted by a ₹70 million inventory write-off following an external warehouse fire, and the absence of a one-time ₹200 million claim income that benefited Q3. Management highlighted that these are transient factors and emphasized that pricing power remains strong, with prices sustained through April and May 2026.
Expansion and Business Verticals
Aether is entering a new growth phase powered by three primary levers: the successful commissioning of Site 3++ and Phase 1 of Site 5, combined with a sharp focus on operational cash flow. The company expects these initiatives to drive the CRAMS and CEM business models to contribute over 70% of total sales in the coming years. Site 4 has already demonstrated 4x growth, reaching ₹220 million and accounting for 21% of total sales.
R&D and Future Preparedness
The company continues to invest heavily in innovation, with interim R&D expansion—including 18 new fume hoods and a new 400 MHz NMR machine—now completed. A much larger R&D facility is on track for commissioning in FY28, featuring 15 new labs and nearly 140 cumulative fume hoods. These investments are designed to support increasing global demand, particularly in the material science and semiconductor spaces, where the company sees opportunities tripling by 2030.
Source: BSE
